1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

Cartana AB

Have updates for this profile?  Please contribute data

About Financials
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Sweden

Primary Industry

Biotechnology

About

Founded in 2017 and based in Solna, Sweden, Cartana AB operates as a biotechnology company that develops spatial sequencing technology, providing simultaneous analysis of hundreds of genes within all cells.
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare IT, Oncology/Cancer Treatment, Medical Devices & Equipment, Analytics & Performance Software
Website
www.cartana.se
Company Stage
Acquired
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2018
502,646
-
(2,869,768)
(570.9%)
(2,741,703)
(545.5%)
(2,873,235)
(571.6%)
31 Dec 2019
3,141,163
524.9%
(3,923,397)
(124.9%)
(3,683,608)
(117.3%)
(3,926,107)
(125%)
31 Dec 2020
31 Dec 2021
31 Dec 2022

Unlock the recent years of financials and more for Cartana AB.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo